We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canadian Drugmakers Expect Higher Costs From EU Proposals
Canadian Drugmakers Expect Higher Costs From EU Proposals
March 15, 2011
A report conducted by Canada’s generics industry shows changes to the country’s drug patent system would add almost $3 billion annually to its drug costs.